BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 15386348)

  • 21. [Studies on antigen associated with human squamous cell carcinoma (SCC antigen) in patients with esophageal carcinoma].
    Hirata S; Yamazaki K; Yokoyama Y; Ueda M; Kubo Y; Samejima N
    Nihon Geka Gakkai Zasshi; 1989 Feb; 90(2):267-72. PubMed ID: 2747608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers.
    Oshima Y; Shimada H; Yajima S; Nanami T; Matsushita K; Nomura F; Kainuma O; Takiguchi N; Soda H; Ueda T; Iizasa T; Yamamoto N; Yamamoto H; Nagata M; Yokoi S; Tagawa M; Ohtsuka S; Kuwajima A; Murakami A; Kaneko H
    J Gastroenterol; 2016 Jan; 51(1):30-4. PubMed ID: 25906289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of matrix metalloproteinase 9 and CD34 expressions in esophageal carcinoma: correlation with DNA content.
    El-Kenawy Ael-M; Lotfy M; El-Kott A; El-Shahat M
    J Clin Gastroenterol; 2005 Oct; 39(9):791-4. PubMed ID: 16145342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trop2 inhibition of P16 expression and the cell cycle promotes intracellular calcium release in OSCC.
    Jia L; Wang T; Ding G; Kuai X; Wang X; Wang B; Zhao W; Zhao Y
    Int J Biol Macromol; 2020 Dec; 164():2409-2417. PubMed ID: 32768481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of human trophoblast cell-surface antigen 2 gene expression by RNA interference on proliferation and apoptosis of tongue squamous cell carcinoma and its mechanism].
    Fang Z; Chen S; Zhao JF; Sun Q; Qiu F; Li XM
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Sep; 53(9):640-644. PubMed ID: 30196628
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical and fundamental study of a squamous cell carcinoma related antigen (SCC-RA) for esophageal squamous cell carcinoma].
    Ikeda K
    Nihon Geka Gakkai Zasshi; 1991 Apr; 92(4):387-96. PubMed ID: 1870566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical impact of TROP2 in non-small lung cancers and its correlation with abnormal p53 nuclear accumulation.
    Mito R; Matsubara E; Komohara Y; Shinchi Y; Sato K; Yoshii D; Ohnishi K; Fujiwara Y; Tomita Y; Ikeda K; Sakagami T; Suzuki M
    Pathol Int; 2020 May; 70(5):287-294. PubMed ID: 32039532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy.
    Yanamoto S; Kawasaki G; Yoshitomi I; Iwamoto T; Hirata K; Mizuno A
    Oral Oncol; 2007 Oct; 43(9):869-77. PubMed ID: 17207659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trop2 is a potential biomarker for the promotion of EMT in human breast cancer.
    Zhao W; Kuai X; Zhou X; Jia L; Wang J; Yang X; Tian Z; Wang X; Lv Q; Wang B; Zhao Y; Huang W
    Oncol Rep; 2018 Aug; 40(2):759-766. PubMed ID: 29901160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical and molecular studies on malignant transformation in mature cystic teratoma of the ovary.
    Yoshioka T; Tanaka T
    J Obstet Gynaecol Res; 1998 Apr; 24(2):83-90. PubMed ID: 9631595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Assay System Elecsys Anti-p53 to Detect Serum Anti-p53 Antibodies in Esophageal Cancer Patients and Colorectal Cancer Patients: Multi-institutional Study.
    Yajima S; Suzuki T; Oshima Y; Shiratori F; Funahashi K; Kawai S; Nanki T; Muraoka S; Urita Y; Saida Y; Okazumi S; Kitagawa Y; Hirata Y; Hasegawa H; Okabayashi K; Murakami M; Yamashita T; Kato R; Matsubara H; Murakami K; Nakajima Y; Sugita H; Klammer M; Shimada H
    Ann Surg Oncol; 2021 Jul; 28(7):4007-4015. PubMed ID: 33210269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new specific gene expression in squamous cell carcinoma of the esophagus detected using representational difference analysis and cDNA microarray.
    Kan T; Yamasaki S; Kondo K; Teratani N; Kawabe A; Kaganoi J; Meltzer SJ; Imamura M; Shimada Y
    Oncology; 2006; 70(1):25-33. PubMed ID: 16446548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma.
    Fukuchi M; Nakajima M; Fukai Y; Miyazaki T; Masuda N; Sohda M; Manda R; Tsukada K; Kato H; Kuwano H
    Int J Cancer; 2004 Mar; 108(6):818-24. PubMed ID: 14712482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-FIRΔexon2, a splicing variant form of PUF60, autoantibody is detected in the sera of esophageal squamous cell carcinoma.
    Kobayashi S; Hiwasa T; Ishige T; Rahmutulla B; Kano M; Hoshino T; Minamoto T; Shimada H; Nomura F; Matsubara H; Matsushita K
    Cancer Sci; 2019 Jun; 110(6):2004-2013. PubMed ID: 30980774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
    PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus.
    Möbius C; Freire J; Becker I; Feith M; Brücher BLDM; Hennig M; Siewert JR; Stein HJ
    World J Surg; 2007 Sep; 31(9):1768-1772. PubMed ID: 17354029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-associated trypsin inhibitor (TATI) in primary esophageal carcinoma.
    Gion M; Mione R; Tremolada C; Dalla Palma P; Ruol A; Dittadi R; Leon A; Nosadini A; Castoro C; Bruscagnin G
    Scand J Clin Lab Invest Suppl; 1991; 207():37-41. PubMed ID: 1780688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolyl isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD1 expression.
    Fukuchi M; Fukai Y; Kimura H; Sohda M; Miyazaki T; Nakajima M; Masuda N; Tsukada K; Kato H; Kuwano H
    Int J Oncol; 2006 Aug; 29(2):329-34. PubMed ID: 16820873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.
    Kunizaki M; Hamasaki K; Wakata K; Tobinaga S; Sumida Y; Hidaka S; Yasutake T; Miyazaki T; Matsumoto K; Yamasaki T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2018 Mar; 38(3):1807-1813. PubMed ID: 29491120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical significance of serum levels of SCC antigen in patients with esophageal squamous cell carcinoma].
    Ikeda K; Terashima M; Ishida K; Okamoto K; Suzuki S; Murakami K; Ohtsu T; Suzuki K; Niitsu Y; Obonai H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):677-82. PubMed ID: 3355186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.